Books > Medicine > Other branches of medicine > Anaesthetics > Pain & pain management
|
Not currently available
Pain Management and the Opioid Epidemic - Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use (Paperback)
Loot Price: R1,643
Discovery Miles 16 430
|
|
Pain Management and the Opioid Epidemic - Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use (Paperback)
Supplier out of stock. If you add this item to your wish list we will let you know when it becomes available.
|
Drug overdose, driven largely by overdose related to the use of
opioids, is now the leading cause of unintentional injury death in
the United States. The ongoing opioid crisis lies at the
intersection of two public health challenges: reducing the burden
of suffering from pain and containing the rising toll of the harms
that can arise from the use of opioid medications. Chronic pain and
opioid use disorder both represent complex human conditions
affecting millions of Americans and causing untold disability and
loss of function. In the context of the growing opioid problem, the
U.S. Food and Drug Administration (FDA) launched an Opioids Action
Plan in early 2016. As part of this plan, the FDA asked the
National Academies of Sciences, Engineering, and Medicine to
convene a committee to update the state of the science on pain
research, care, and education and to identify actions the FDA and
others can take to respond to the opioid epidemic, with a
particular focus on informing FDA's development of a formal method
for incorporating individual and societal considerations into its
risk-benefit framework for opioid approval and monitoring. Table of
Contents Front Matter Summary 1 Introduction PART I: PAIN
MANAGEMENT AND RESEARCH 2 Pain Management and the Intersection of
Pain and Opioid Use Disorder 3 Progress and Future Directions in
Research on Pain and Opioid Use Disorder PART II: ADDRESSING THE
OPIOID EPIDEMIC 4 Trends in Opioid Use, Harms, and Treatment 5
Evidence on Strategies for Addressing the Opioid Epidemic 6 Opioid
Approval and Monitoring by the U.S. Food and Drug Administration
APPENDIXES Appendix A: Data Sources and Methods Appendix B:
Biographical Sketches of Committee Members and Consultants Appendix
C: Existing Data Sources on Opioid Use, Misuse, Overdose, and Other
Harms
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.